|
Companies With Gaps in Supplier Audits Should Beef Up Incoming Acceptance
While drugmakers should not rely on a “Plan B” for validating suppliers, there are some steps they can take if they can’t conduct sufficient quality audits — primarily beefing up incoming acceptance activities, compliance experts say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives